Plain-English translation of NCT06009523 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing transcranial direct current stimulation (tDCS), a non-invasive procedure that uses mild electrical current to stimulate specific areas of the brain. The study focuses on helping people with severe, treatment-resistant depression who are having thoughts of suicide. Researchers want to see if this treatment can reduce these dangerous thoughts when standard antidepressant medications haven't worked well enough.
Depression that doesn't respond adequately to antidepressant medications, especially when combined with suicidal thoughts, is a serious medical emergency. This treatment is being studied because it offers a potentially faster way to reduce the risk of suicide in people who have already tried multiple medications without sufficient relief.
You likely qualify if…
You likely don't qualify if…
If you qualify, you'll receive 15 daily sessions of transcranial direct current stimulation, with each session lasting about 30 minutes. During the procedure, small electrodes are placed on your scalp to deliver a mild, painless electrical current to targeted brain areas. After your last treatment session, you'll have three follow-up visits over the next 2.5 months (approximately 19, 49, and 79 days after starting) so researchers can track how you're doing.
AI-generated summary from trial data · Jun 23, 2026 · Not medical advice
France